Roivant Sciences secures $5.2B for advancing late-stage drugs like IMVT-1402 & brepocitinib. Click here to read an analysis ...

Unusual total active option classes on open include: Appian Corp ( APPN ), Organon and Co ( OGN ), DuPont de Nemours ( DD ), ISHARES ETHEREUM TRUST ETF (ETHA), iShares Nasdaq Biotechnology Index Fund ...

A number of stocks jumped in the afternoon session after investor sentiment improved on renewed optimism that the US-China ...

LAGOS – In a strategic effort to elevate youth voices in sexual and reproductive health and rights (SRHR), the African Youth and Adolescent Network (AfriYAN) Nigeria, supported by Organon, has ...

In a strategic effort to elevate youth voices in sexual and reproductive health and rights (SRHR), the African Youth and ...

Knipper Health, a leading healthcare solutions organization serving the pharmaceutical, biotechnology, and medical device ...

Galderma has kicked off an ad campaign to show how its Nemluvio can empower people to rule over itchy eczema. Aiming to grow ...

Elevance Health (ELV) came out with quarterly earnings of $11.97 per share, beating the Zacks Consensus Estimate of $11.21 per share. This compares to earnings of $10.64 per share a year ago. These ...

BofA lowered the firm’s price target on Organon (OGN) to $11 from $15 and keeps an Underperform rating on the shares. The firm, in its preview ...

Eli Lilly and Co. aired positive top-line data from the phase III trial called Achieve-1 testing orforglipron vs. placebo in adults with type 2 diabetes and inadequate glycemic control with diet and ...